...
首页> 外文期刊>Microbiologia Medica >Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist
【24h】

Role of interferon-gamma release assays (IGRAs) for the screening of latent tuberculosis infection in patients candidates for TNF-α antagonist

机译:干扰素-γ释放试验(IGRA)在筛选TNF-α拮抗剂候选患者的潜伏性结核感染中的作用

获取原文

摘要

Background: Tumor necrosis factor-α (TNF-a) inhibitors are associated with an increased risk of reactivation of latent tuberculosis infection (LTBI); thus, the guidelines recommends TB screening for all patients before starting anti-TNF-α therapy.The use of tuberculin skin test (TST) is controversial because of the immunosuppressive treatment may lead to false-negative TST results and previous BCG-vaccination produces false-positive. The introduction in clinical practice of the interferon-gamma release assays (IGRAs) has opened new perspectives for diagnosis of LTBI.The aim of the study was to investigate the performance of QuantiFERON-TB Gold In Tube assay (QFT-GIT) for the diagnosis of LTBI in patients with an immune-mediated inflammatory diseases candidates for anti-TNF-α therapy. Methods:We enrolled 195 patients with rheumatoid arthritis (n=72), psoriatic arthritis (n=40), psoriasis (n=41), ankylosing spondylitis (n=10), Crohn’s disease (n=18), and Behcet’s disease (n=8). Screening included: clinical evaluation, chest X-ray,TST and QFT-GIT. Results: Of the 195 patients, 32 (16.4%), 137 (70.2%) and 26 (13.3%) tested positive, negative and indeterminate with QFT-GIT test, respectively. The level of agreement between two tests was 81.6 % (k=0.55). Among the screened patients, 38 (19%) were considered to have LTBI and received isoniazid treatment, while 31 patients (16%) showed discordant results between two tests. Univariate analysis showed an association between BCG vaccination and discordant TST-positive/QFT-GIT-negative results (OR=6; 95%CI: 2.3-37.1; p<0.001); no association was observed between the immunosuppressive therapy and discordant TST-negative/QFT-GIT-positive results (OR=0.16; 95%CI: 0.01-1.8; p<0.09). Conclusions: Our results suggest that QFT-GIT may be helpful for the diagnosis of LTBI in patients candidates for anti-TNF-α treatment because of its performance seems to not be affected by any type of immunosuppression.
机译:背景:肿瘤坏死因子-α(TNF-a)抑制剂与潜伏性结核感染(LTBI)的再激活风险增加有关;因此,该指南建议在开始抗TNF-α治疗之前对所有患者进行结核病筛查。结核菌素皮肤试验(TST)的使用存在争议,因为免疫抑制治疗可能导致TST结果为假阴性,而以前的BCG疫苗接种会产生假-正。干扰素-γ释放测定(IGRA)在临床实践中的介绍为LTBI的诊断开辟了新的视角。该研究的目的是研究QuantiFERON-TB黄金管内测定(QFT-GIT)在诊断中的性能在免疫介导的炎症性疾病患者中进行LTBI的抗TNF-α治疗。方法:我们招募了195例风湿性关节炎(n = 72),银屑病关节炎(n = 40),牛皮癣(n = 41),强直性脊柱炎(n = 10),克罗恩病(n = 18)和白塞氏病( n = 8)。筛查包括:临床评估,胸部X线,TST和QFT-GIT。结果:在195例患者中,QFT-GIT检验分别为阳性,阴性和不确定,分别为32例(16.4%),137例(70.2%)和26例(13.3%)。两次测试之间的一致性水平为81.6%(k = 0.55)。在筛查的患者中,38例(19%)被认为患有LTBI并接受了异烟肼治疗,而31例患者(16%)在两次检查之间显示出不一致的结果。单因素分析表明,卡介苗接种和TST阳性/ QFT-GIT阴性结果不一致(OR = 6; 95%CI:2.3-37.1; p <0.001);在免疫抑制疗法和不一致的TST阴性/ QFT-GIT阳性结果之间未发现关联(OR = 0.16; 95%CI:0.01-1.8; p <0.09)。结论:我们的结果表明,QFT-GIT可能有助于抗TNF-α治疗候选患者的LTBI诊断,因为其性能似乎不受任何类型的免疫抑制的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号